# ImmuneWorks

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/immuneworks

- Industry: Biotechnology
- Headquarters: Indianapolis, US
- Website: www.immuneworks.com
- Total disclosed funding: $0.3M
- Latest round: Seed (Oct 30, 2007)
- Investors on record: 1

## About

ImmuneWorks is a company focused on enhancing online presence through premium domain name sales and branding services, catering to both startups and established businesses.ImmuneWorks, founded in 2006 and headquartered in Indianapolis, US, specializes in digital domain services. The company has completed 4 deals, with its most recent funding round occurring on December 26, 2013, raising USD 0.06 million. There is no mention of notable pivots or changes in business operations, nor any affiliated parent or subsidiary companies.ImmuneWorks specializes in providing a diverse range of digital domain services, emphasizing the sale of premium domain names. Their primary offerings include expert-curated domains, which are designed to be brandable and suitable for various business needs. The company caters to businesses looking for impactful online presence, facilitating the purchase of one-word domains and modern domain extensions such as .ai, .io, and .xyz. ImmuneWorks also offers comprehensive naming and branding services, including contests for unique name ideas and AI-assisted logo creation, enabling clients to establish memorable brands quickly. The targeted geographical markets for these services encompass a global audience, with clients ranging from startups to established enterprises seeking to enhance their digital identity.ImmuneWorks generates revenue primarily through the sale of domain names and associated branding services. Transactions typically occur on a direct-to-consumer basis, where customers purchase domains through a one-time payment structure facilitated by secure escrow services. The company also offers payment plans, allowing clients to make smaller monthly installments for premium domains while enabling immediate use after the first payment. Additional revenue streams may include trademark validation and filing services, as well as branding consultations. Pricing structures are established for various services, including flagship offerings that are integral to ImmuneWorks' appeal in the marketplace. The firm’s strong customer base consists of individuals and businesses aiming to secure their online identity and protect their brand.ImmuneWorks plans to utilize its recent funding of USD 0.06 million raised in December 2013 to develop new products and expand its offerings. The company aims to enhance its branding services and launch innovative digital solutions within the next year. Additionally, it is exploring expansion into emerging markets in Asia and Europe, targeting a broader client base by 2025. These initiatives are expected to strengthen its presence in the competitive digital domain industry.

## Funding rounds

- Seed, Oct 30, 2007, $0.3M — BioCrossroads

## Investors

- BioCrossroads (https://capitalatlas.ai/funds/biocrossroads) — Seed